To include your compound in the COVID-19 Resource Center, submit it here.

Neumega oprelvekin: Marketed

In 4 patients with chronic hepatitis C virus (HCV) infection,

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE